Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0086 USD | -.--% | -.--% | -95.41% |
05-28 | Peak Bio, Inc. announced that it has received $1.3245 million in funding | CI |
03-05 | Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc.. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-95.41% | 199K | |
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- PKBO Stock
- News Peak Bio, Inc.
- Ladenburg Thalmann Initiates Peak Bio at Buy Rating With $15 Price Target